March 06, 2013 IMPORTANT NOTIFICATION Discontinuation of the RIBA® Product Line, Including CHIRON® RIBA® HCV 3.0 SIA (Product Code[removed]Dear OCD Customer:

First Page		Document Content
Date: 2014-09-29 19:30:55 Ortho-Clinical Diagnostics Riba Pharmaceutics Pharmaceutical industry Chiron Corporation Novartis		March 06, 2013 IMPORTANT NOTIFICATION Discontinuation of the RIBA® Product Line, Including CHIRON® RIBA® HCV 3.0 SIA (Product Code[removed]Dear OCD Customer: Add to Reading List Source URL: www.cdph.ca.gov Download Document from Source Website File Size: 116,85 KB Share Document on Facebook

	Applied Proteomics Appoints Erwin Estigarribia as Vice President, Commercial Operations SAN DIEGO – May 07, 2015 -‐ Applied P DocID: 1r1cm - View Document
	Australian start-up Chiron Global receives Series B funding Australian-based company Chiron Global, parent company of Unified Weapons Master (UWM), today announced that it has secured Series B funding from an unnamed hig DocID: 11KLY - View Document
	AABB 53rd Annual M.eeting November 7,200O Multiplex NAT Reactive Donor Specimens Tested Non-Reactive in Discriminatory Assays are DocID: S3BQ - View Document
	Microsoft PowerPoint[removed]Swiss Export Day Kim Stratton - final.pptx DocID: OWkO - View Document
	L A B O R A T O R Y Technical Bulletin August 3, 2009 DocID: N8D0 - View Document